Condition: Purpura, Thrombocytopenic · Sponsor: Fundación Española de Hematología y Hemoterapía
REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated. The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.
This description comes directly from the study's public registry record.
Contact person Designated by the Sponsor · +34934344412 · investigacion@mfar.net
Always discuss trial participation with your own doctor first.
| Hospital Universitario Virgen del Rocío | Seville, Andalusia, Spain | Recruiting |
| Hospital Universitario Bellvitge | L'Hospitalet de Llobregat, Barcelona, Spain | Recruiting |
| Hospital Clínic Barcelona | Barcelona, Spain | Recruiting |
| Hospital Universitario de Guadalajara | Guadalajara, Spain | Recruiting |
| Hospital Universitario La Paz | Madrid, Spain | Recruiting |
| Hospital Virgen de la Arrixaca | Murcia, Spain | Recruiting |
| Hospital Clínico Universitario de Valencia | Valencia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05914441